Fibnib 150mg Soft Gelatin Capsule is primarily used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF is an irreversible disease marked by a progressive decline in lung function. The tissues in the lungs become swollen and scarred over time, which makes it difficult to breathe deeply.

Fibnib 150mg Soft Gelatin Capsule contains nintedanib, which helps reduce the scarring and swelling in the lungs by decreasing the release of naturally occurring growth factors in the body, allowing you to breathe better.

In some cases, you may experience common side effects such as nausea, tiredness, diarrhoea, indigestion, loss of appetite, headache, and photosensitivity. Most of these side effects do not require medical attention and will resolve gradually over time. However, talk to your doctor if you experience these side effects persistently.

Inform your doctor if you are allergic to Fibnib 150mg Soft Gelatin Capsule. Consult your doctor before taking Fibnib 150mg Soft Gelatin Capsule if you are pregnant or breastfeeding. Fibnib 150mg Soft Gelatin Capsule is not recommended for children below 18 years as safety and effectiveness have not been established. Consult your doctor if you are breastfeeding; your doctor will decide whether Fibnib 150mg Soft Gelatin Capsule can be taken by breastfeeding mothers or not.

Fibnib 150mg Soft Gelatin Capsule is used in the treatment of Idiopathic pulmonary fibrosis. The detailed uses of Fibnib 150mg Soft Gelatin Capsule are as follows: Treatment of Idiopathic pulmonary fibrosis

• Idiopathic pulmonary fibrosis: Fibnib 150mg Soft Gelatin Capsule aids in the breakdown and thinning of mucus in the airways, facilitating coughing and removal. It is especially beneficial in conditions like Idiopathic pulmonary fibrosis.

• Fibnib 150mg Soft Gelatin Capsule should be taken with meals to enhance its effectiveness.
• It is recommended to take Fibnib 150mg Soft Gelatin Capsule twice daily or as advised by your doctor.
• Swallow Fibnib 150mg Soft Gelatin Capsule as a whole with a glass of water.
• Do not crush, chew, or open it.

• Fibnib 150mg Soft Gelatin Capsule is an anti-fibrotic medicine used to treat idiopathic pulmonary fibrosis (IPF) in adults.
• Fibnib 150mg Soft Gelatin Capsule can help effectively slow the rate of lung function decline by 50%.
• Fibnib 150mg Soft Gelatin Capsule helps reduce the scarring and swelling in the lungs by decreasing the release/activity of naturally occurring growth factors in the body, allowing you to breathe better.
• Fibnib 150mg Soft Gelatin Capsule helps in slowing down the progress of idiopathic pulmonary fibrosis.

• Do not use Fibnib 150mg Soft Gelatin Capsule if you are allergic to any components present in Fibnib 150mg Soft Gelatin Capsule.
• Fibnib 150mg Soft Gelatin Capsule can cause harm to the fetus, women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with Fibnib 150mg Soft Gelatin Capsule.
• Consult your doctor if you are breastfeeding; your doctor will decide whether the Fibnib 150mg Soft Gelatin Capsule can be taken by breastfeeding mothers or not.
• Keep your doctor informed about your health condition and medicines to rule out any side effects. 
• Fibnib 150mg Soft Gelatin Capsule may cause tiredness and dizziness, so drive with caution.
• Avoid consuming alcohol with Fibnib 150mg Soft Gelatin Capsule as it could lead to increased dizziness.
• Fibnib 150mg Soft Gelatin Capsule is not recommended for children below 18 years as safety and effectiveness have not been established.